BACKGROUND: Condom use is a primary prevention strategy for sexually transmitted infections (STIs). Consistent condom use substantially reduces the risk of HIV infection. Similar levels of effectiveness for reducing the risk of other STIs have not been established. Differences in disease-specific infectivity and the number of exposures to an infected partner may explain differences in condom effectiveness. GOAL: The goal was to examine the impact of differing infectivities and increasing numbers of exposures on theoretical condom effectiveness. STUDY DESIGN: Mathematical modeling using estimated disease-specific infectivities and condom failure rates. RESULTS: Condom effectiveness decreases as disease-specific infectivity and the number of exposures to infection risk increase. CONCLUSIONS: Condom effectiveness for decreasing STI risk is influenced by disease infectivity and the number of exposures. Generalizations from studies of relatively uninfectious STIs to highly infectious STIs or from short-term studies to longer-term situations will overestimate condom effectiveness.
BACKGROUND: Condom use is a primary prevention strategy for sexually transmitted infections (STIs). Consistent condom use substantially reduces the risk of HIV infection. Similar levels of effectiveness for reducing the risk of other STIs have not been established. Differences in disease-specific infectivity and the number of exposures to an infected partner may explain differences in condom effectiveness. GOAL: The goal was to examine the impact of differing infectivities and increasing numbers of exposures on theoretical condom effectiveness. STUDY DESIGN: Mathematical modeling using estimated disease-specific infectivities and condom failure rates. RESULTS: Condom effectiveness decreases as disease-specific infectivity and the number of exposures to infection risk increase. CONCLUSIONS: Condom effectiveness for decreasing STI risk is influenced by disease infectivity and the number of exposures. Generalizations from studies of relatively uninfectious STIs to highly infectious STIs or from short-term studies to longer-term situations will overestimate condom effectiveness.
Authors: Roberta B Ness; Hugh Randall; Holly E Richter; Jeffrey F Peipert; Andrea Montagno; David E Soper; Richard L Sweet; Deborah B Nelson; Diane Schubeck; Susan L Hendrix; Debra C Bass; Kevin E Kip Journal: Am J Public Health Date: 2004-08 Impact factor: 9.308
Authors: Ann N Burchell; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco Journal: Sex Transm Dis Date: 2010-01 Impact factor: 2.830
Authors: Lori L Heise; Charlotte Watts; Anna Foss; James Trussell; Peter Vickerman; Richard Hayes; Sheena McCormack Journal: Contraception Date: 2010-08-07 Impact factor: 3.375
Authors: Catherine R H Aicken; Nigel T Armstrong; Jackie A Cassell; Neil Macdonald; Angela C Bailey; Sandra A Johnson; Catherine H Mercer Journal: BMC Health Serv Res Date: 2012-07-17 Impact factor: 2.655
Authors: Isaac C-H Fung; Lorna Guinness; Peter Vickerman; Charlotte Watts; Gangadhar Vannela; Jagdish Vadhvana; Anna M Foss; Laxman Malodia; Meena Gandhi; Gaurang Jani Journal: BMC Public Health Date: 2007-08-06 Impact factor: 3.295